The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $70.61

Today's change-2.03 -2.79%
Updated June 24 4:04 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $70.61

Today's change-2.03 -2.79%
Updated June 24 4:04 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$2.03

Bristol-Myers Squibb Co closed sharply lower Friday, dropping (U.S.)$2.03 or 2.79% to (U.S.)$70.61. This security is unchanged over the last five days and the last 52 weeks. This security has outperformed the S&P 500 by 9.06% during the last year.

Key company metrics

  • Open(U.S.) $70.75
  • Previous close(U.S.) $72.64
  • High(U.S.) $71.85
  • Low(U.S.) $70.53
  • Bid / Ask(U.S.) $70.67 / (U.S.) $70.98
  • YTD % change+2.65%
  • Volume7,413,729
  • Average volume (10-day)7,152,305
  • Average volume (1-month)5,976,608
  • Average volume (3-month)6,042,326
  • 52-week range(U.S.) $51.82 to (U.S.) $75.12
  • Beta0.51
  • Trailing P/E75.43×
  • P/E 1 year forward27.85×
  • Forward PEG1.22×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.15%
  • Trailing EPS(U.S.) $0.94
Updated June 24 4:04 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,3914,2874,0694,163
Total other revenue--------
Total revenue4,3914,2874,0694,163
Gross profit3,3433,3452,9873,175
Total cost of revenue1,0489421,082988
Total operating expense2,7414,5823,4134,216
Selling / general / administrative1,0681,5011,1761,135
Research & development1,1361,7561,1321,856
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-25738323237
Other operating expenses, total-254------
Operating income1,650-295656-53
Interest income (expense), net non-operating-43-43-41-49
Gain (loss) on sale of assets---1742088
Other--------
Income before tax1,655-41098752
Income after tax1,206-188730-110
Income tax, total449-222257162
Net income1,195-197706-130
Total adjustments to net income--------
Net income before extra. items1,195-197706-130
Minority interest-11-9-24-20
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,195-197706-130
Inc. avail. to common incl. extra. items1,195-197706-130
Diluted net income1,195-197706-130
Dilution adjustment--------
Diluted weighted average shares1,6801,6701,6781,667
Diluted EPS excluding extraordinary itemsvalue per share0.71-0.120.42-0.08
Dividends per sharevalue per share0.380.380.370.37
Diluted normalized EPSvalue per share0.600.130.300.01